Bottom line
RAGHX vs SCHLX: the short answer
RAGHX (Virtus KAR Health Sciences Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 52% by weight.
But SCHLX is far broader, holding 65 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
SCHLX is cheaper at 1.06% vs 1.41% — a difference of $35 a year per $10,000 invested.
RAGHX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
RAGHX vs SCHLX side by side
| RAGHX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Virtus | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.41% | 1.06% |
| Annual cost per $10k | $141 | $106 |
| 10-yr cost on $10k (prospectus) | $2,148 | $1,294 |
| Max front load | 5.5% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +1.3% | — |
| 5-yr return (annualized) | +2.4% | — |
| 10-yr return (annualized) | +6.2% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $91.7M | $231.8M |
| Number of holdings | 24 | 65 |
| Portfolio turnover | 13% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of RAGHX's top 24 holdings also appear in SCHLX's top 25.
| Holding | RAGHX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 14.84% | 13.85% |
| Abbvie Inc | 5.52% | 4.90% |
| Vertex Pharmaceuticals Inc | 5.32% | 2.45% |
| Merck & Company Inc | 5.06% | 4.85% |
| Unitedhealth Group Inc | 4.65% | 5.73% |
| Mckesson Corp | 4.57% | 2.05% |
| Intuitive Surgical Inc | 3.89% | 2.69% |
| Amgen Inc | 3.85% | 2.88% |
| Thermo Fisher Scientific Inc | 3.65% | 3.46% |
| Danaher Corp | 3.37% | 2.13% |
| Regeneron Pharmaceuticals Inc | 2.90% | 1.43% |
Source: SEC Form N-PORT
RAGHX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between RAGHX and SCHLX?
Which is cheaper, RAGHX or SCHLX?
Should I own both RAGHX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.